Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kuliczkowski

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Roczniki Akademii Medycznej W Bialymstoku (1995)|January 11, 2005
Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasiaG Mazur, A Haloń, T Wróbel, et al.
Clinical and Laboratory Haematology|January 25, 2006
sVE-cadherin and sCD146 serum levels in patients with multiple myelomaT Wrobel, G Mazur, D Wolowiec, et al.
Polskie Archiwum Medycyny Wewnetrznej|March 10, 2001
[Cytogenetic changes in Ph(+) chronic granulocytic leukemia under the influence of interferon alpha (IFN-alpha) therapy]O Haus, S Kotlarek-Haus, I Makowska, et al.
Neoplasma|September 8, 2007
Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemiaG Mazur, T Wróbel, A Butrym, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Comparison of autoradiography and DNA histograms in assessing S-phase cells from patients with myeloid leukemiasA Raza, A S Raza, K Kuliczkowski, et al.
Medycyna Doswiadczalna I Mikrobiologia|January 1, 1988
[Studies of the phagocytic process in Hodgkin's disease. I. Effect of patients' sera on the process of phagocytosis and intracellular bactericidal activity]K Grzybek-Hryncewicz, M Melezyńska-Matej, S Kotlarek-Haus, et al.
Polskie Archiwum Medycyny Wewnetrznej|January 5, 2002
[Serum soluble tumor necrosis factor alpha receptor (s-TNF-alpha R) and acute phase proteins as factors of a disease activity (and also as prognostic factors?) in patients with malignant lymphomas]K Kapelko-Słowik, D Urbaniak-Kujda, B Jaźwiec, et al.
Leukemia Research|April 1, 1995
Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPAK Kuliczkowski, R L Darley, A Jacobs, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 3, 2007
Treatment of cutaneous T-cell lymphomas with purine analogues (fludarabine and 2-chlorodeoxyadenosine)G Mazur, J Maj, T Wrobel, et al.
HLA|May 14, 2016
Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemiaA Butrym, K Gebura, M Iwaszko, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Roczniki Akademii Medycznej W Bialymstoku (1995)|January 11, 2005
Survivin expression in lymph nodes, affected by lymphoma and reactive hyperplasiaG Mazur, A Haloń, T Wróbel, et al.
Clinical and Laboratory Haematology|January 25, 2006
sVE-cadherin and sCD146 serum levels in patients with multiple myelomaT Wrobel, G Mazur, D Wolowiec, et al.
Polskie Archiwum Medycyny Wewnetrznej|March 10, 2001
[Cytogenetic changes in Ph(+) chronic granulocytic leukemia under the influence of interferon alpha (IFN-alpha) therapy]O Haus, S Kotlarek-Haus, I Makowska, et al.
Neoplasma|September 8, 2007
Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemiaG Mazur, T Wróbel, A Butrym, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1985
Comparison of autoradiography and DNA histograms in assessing S-phase cells from patients with myeloid leukemiasA Raza, A S Raza, K Kuliczkowski, et al.
Medycyna Doswiadczalna I Mikrobiologia|January 1, 1988
[Studies of the phagocytic process in Hodgkin's disease. I. Effect of patients' sera on the process of phagocytosis and intracellular bactericidal activity]K Grzybek-Hryncewicz, M Melezyńska-Matej, S Kotlarek-Haus, et al.
Polskie Archiwum Medycyny Wewnetrznej|January 5, 2002
[Serum soluble tumor necrosis factor alpha receptor (s-TNF-alpha R) and acute phase proteins as factors of a disease activity (and also as prognostic factors?) in patients with malignant lymphomas]K Kapelko-Słowik, D Urbaniak-Kujda, B Jaźwiec, et al.
Leukemia Research|April 1, 1995
Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPAK Kuliczkowski, R L Darley, A Jacobs, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 3, 2007
Treatment of cutaneous T-cell lymphomas with purine analogues (fludarabine and 2-chlorodeoxyadenosine)G Mazur, J Maj, T Wrobel, et al.
HLA|May 14, 2016
Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemiaA Butrym, K Gebura, M Iwaszko, et al.
Pageof 10